Projected Price to Earnings: Nevro Corporation (NVRO)

NVRO (Nevro Corp.) - company brandmark

Precision robotic assembly of implants provides Nevro Corp. (NVRO) with high product reliability. The company's forward 12-month P/E visualizes this potential, while the 0.00 metric confirms the current level. However, pricing pressure and competition create margin risks, forcing the business to undergo operational restructuring to protect profits amid market stagnation.

nevro.com - NVRO Market Cap to Future Earnings Ratio (period 07/04/2022 - 04/13/2025)

Metric breakdowns and analytics for Nevro Medical (NVRO)

- stock quotes and analyst forecast:
Stock Price Nevro|NVRO - Average Forecast Price
- company stock exchange capitalization indicators:
Market Valuation Nevro Corp|NVRO - Enterprise Value
- issuer book value statistics:
Accounting Value per Share Nevro|NVRO - Total Net Assets|Market Capitalization to Book Value Ratio nevro.com|NVRO - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital Nevro Corp.|NVRO - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Nevro Corp.|NVRO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Nevro Corp|NVRO - Company Long-Term Liabilities|Company Short-Term Debts Nevro|Quick Ratio nevro.com
- financial results and valuation multiples details:
NVRO - Company Profit|Projected Future Earnings Nevro Corp.|NVRO - Business Payback Period|Forward P/E Multiple Nevro Corporation|NVRO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Nevro Corp|NVRO - Operating profit EBITDA|Earnings per share for the last twelve months Nevro|NVRO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months nevro.com|NVRO - Earnings per share increase in current year|Earnings growth forecast for next year Nevro Corp.
Fundamental valuation:NVRO Nevro
Brand item of nevro.com

This indicator compares the current market value of the business with updated earnings forecasts, allowing for a forward-looking assessment of the asset's investment attractiveness. By analyzing the future price-to-earnings ratio of Nevro Corp. (NVRO), investors can see how the company's ESG initiatives to create durable implants and reduce its carbon footprint impact expected capitalization and the overall market maturity of the issuer.

Competitors of Nevro Corp.

Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Novanta Corp - Projected Price to Earnings|Forward P/E Multiple Haemonetics Company HAE|INSP: Projected Price to Earnings|procept-biorobotics.com - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (InMode Corp) - Forward P/E Multiple|Projected Price to Earnings Picard Group (PMI)|Projected Price to Earnings SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Outset Medical Corp|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical) - Forward P/E Multiple|Profound Medical Corporation (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple BDMD|Projected Price to Earnings edap-tms.com EDAP|Forward P/E Multiple APYX (Apyx Medical Corporation)|Forward P/E Multiple IceCure Medical Ltd. ICCM|LUNG - Future Price to Earnings|TELA: Future Price to Earnings|CTSO (cytosorbents.com) - Projected Price to Earnings|Sensus - Future Price to Earnings Multiple|ZYXI (Zynex, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio electroCore Medical ECOR|Future Price to Earnings Vicarious Surgical Inc. (RBOT)|inspira-technologies.com (IINN) - Forward Price to Earnings Multiple|SeaStar Medical Holding Corp - Projected Price to Earnings|Forward P/E Multiple IRIDEX Corp IRIX|Intelligent Bio - Forward P/E Multiple|Market Cap to Projected Earnings Beyond Air, Inc. XAIR|Profusa (PFSA) - Future Price to Earnings|Price to Expected Earnings Ratio SSKN (STRATA Skin Sciences, Inc.)|Future Price to Earnings GlucoTrack|Projected Price to Earnings NanoVibronix Inc. (NAOV)|Forward P/E Multiple VERO|NUWE - Projected Price to Earnings Ratio|Future Price to Earnings Aethlon Medical, Inc. AEMD|ASXC: Price to Future Earnings Ratio|AVGR: Projected Price to Earnings|BioSig Technologies - Market Cap to Future Earnings Ratio|Cutera, Inc. (CUTR) - Future Price to Earnings|Price to Future Earnings Ratio KNW|NARI (Inari Medical) - Forward P/E Multiple|Projected Price to Earnings Ratio ReShape Lifesciences Inc RSLS|Projected Price to Earnings SILK (Silk Road Medical Inc.)